Operative Dictations in Urologic Surgery
Armenakas NA, Fracchia JA, Golan R. Urethrectomy (male). Chapter 67. Wiley, 2019
The indications, the six essential steps and their order, the template dictation followed step by step here, the variations (en bloc with cystectomy, an inverted-U or inverted-Y incision, a tourniquet at the base of the penis, an optional drain) and the complication list: bleeding, infection, abscess, bowel injury, erectile dysfunction. The chapter passes the catheter to the bladder; in this scenario there is no bladder, so it is shown passing to the blind stump. The scene is schematic: the invagination is drawn as the shaft folded into the wound with its skin as a faint sleeve, and the conduit is named but not drawn. The chapter lists complications without their management. The first, escalate and document steps, the troubleshooting line on a stump that will not come down, and the danger lines not traceable to the dictation are general surgical practice.
Open guideline
EAU Guidelines
Muscle-invasive and Metastatic Bladder Cancer, 2026: Recurrent disease, sections 8.4 Urethral recurrence and 8.6, read 13 October 2026
Urethral recurrence-related death is rare and prophylactic urethrectomy shows no survival benefit; a systematic review incidence of 4.4% (1.3 to 13.7%); prostatic urethra or prostate involvement as the risk factor in men; lower risk with an orthotopic neobladder (odds ratio 0.44); limited data on urethral follow-up, with a survival advantage in men diagnosed before symptoms; BCG for urethral carcinoma in situ, citing the Varol series listed below; urethrectomy for invasive disease if the urethra is the only site; a secondary urethral tumour staged and treated as a primary one (strong).
Open guideline
EAU Guidelines
Muscle-invasive and Metastatic Bladder Cancer, 2026: Disease management, sections 6.7.5.b and 6.7.5.d, read 13 October 2026
An invasive urethral tumour diagnosed before cystectomy leads to urethrectomy and is a contraindication to a neobladder; do not offer an orthotopic bladder substitute to patients with an invasive tumour in the urethra or at the level of urethral dissection (strong).
Open guideline
EAU Guidelines
Primary Urethral Carcinoma, 2026: Disease management, sections 7.1 and 7.4, read 13 October 2026
Background for the other two indications the chapter lists. For localised distal tumours in men, distal urethrectomy is offered as an alternative to penile amputation if negative margins can be achieved (weak), with complete circumferential assessment of the proximal urethral margin (strong). For non-invasive carcinoma of the prostatic urethra, a urethra-sparing approach with resection and BCG (strong). Not used for any statement about technique.
Open guideline
Urologic Oncology
Fahmy O et al. Urethral recurrence after radical cystectomy for urothelial carcinoma: a systematic review and meta-analysis. Urol Oncol 2018;36:54-59
Abstract read 13 October 2026. Fourteen retrospective studies, 6,169 patients: incidence 4.4% (1.3 to 13.7%); lower with neobladder diversion (odds ratio 0.44, 95% CI 0.24 to 0.79); muscle invasion, carcinoma in situ and prostatic stromal or urethral involvement not significant. This is the review the guideline figure comes from.
Open guideline
The Journal of Urology
Varol C, Thalmann GN, Burkhard FC, Studer UE. Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol 2004;172:937-942
Abstract read 13 October 2026. Fifteen of 371 men with an orthotopic bladder substitute had a urethral recurrence. Five of six with carcinoma in situ stayed free of recurrence after intraurethral BCG; it failed in four with papillary or invasive disease, and the authors advise urethrectomy for those. This is the source of the guideline figure of 83%; the men had a neobladder, so the figure does not transfer directly to a man with a conduit.
Open guideline
Urologic Oncology
Laukhtina E et al. Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: a systematic review and meta-analysis. Urol Oncol 2021;39:806-815
Abstract read 13 October 2026. Twenty-one studies, 9,435 patients: lower odds with an orthotopic neobladder (pooled odds ratio 0.44), higher in men than women (3.16); prostatic urethral involvement (hazard ratio 5.44), prostatic stromal involvement (5.90) and multifocality (2.97) associated with urethral recurrence; five-year cancer-specific survival of 47% to 63% in patients with urethral recurrence, which did not appear related to worse survival.
Open guideline